Study #PA13-0705
Assessment of Plasma Tumor DNA as a Marker of Minimal Residual Disease in Acute Leukemia
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Plasma tumor DNA for MRD assessment
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Not applicable
Physician name:
Farhad Ravandi-Kashani
Department:
Leukemia
For general questions about clinical trials:
1-844-720-2303
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.